Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Mutual Funds
Invest in Mutual Funds
Invest in direct mutual funds at zero charges via lump sump investments or SIPs
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth
Equity
Sectoral
Very High Risk
+19.37%
3Y annualised
-1.06% 1D
NAV: 16 Jan '26
₹21.32
Min. SIP amount
₹100
Fund size
₹170.77 Cr
Expense ratio
0.52%
Return calculator
Monthly SIP
Monthly investment
₹5,000
| Over the past | Total investment | Would've become | Historic returns | Returns |
|---|---|---|---|---|
| 1 year | ₹60,000 | ₹62,883 | +4.81% | |
| 3 years | ₹1,80,000 | ₹2,30,453 | +28.03% | |
| 5 years | ₹3,00,000 | ₹4,39,979 | +46.66% |
Holdings (45)
| Name | Sector | Instruments | Assets |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Healthcare | Equity | 10.98% |
| Eli Lilly And Co | Healthcare | Forgn. Eq | 6.97% |
| Cipla Ltd. | Healthcare | Equity | 5.69% |
| Max Healthcare Institute Ltd. | Healthcare | Equity | 5.41% |
| Divi's Laboratories Ltd. | Healthcare | Equity | 5.08% |
| Apollo Hospitals Enterprise Ltd. | Healthcare | Equity | 5.05% |
| Dr. Reddy's Laboratories Ltd. | Healthcare | Equity | 4.59% |
| Johnson & Johnson Ltd. | Healthcare | Forgn. Eq | 4.02% |
| Lupin Ltd. | Healthcare | Equity | 3.53% |
| AbbVie Inc | Healthcare | Forgn. Eq | 3.25% |
| Torrent Pharmaceuticals Ltd. | Healthcare | Equity | 3.03% |
| Fortis Healthcare Ltd. | Healthcare | Equity | 2.89% |
| Laurus Labs Ltd. | Healthcare | Equity | 2.59% |
| Merck & Co Inc (US) | Healthcare | Forgn. Eq | 2.12% |
| Novartis AG | Healthcare | ADS/ADR | 2.11% |
| Glenmark Pharmaceuticals Ltd. | Healthcare | Equity | 2.10% |
| Aurobindo Pharma Ltd. | Healthcare | Equity | 2.06% |
| Mankind Pharma Ltd. | Healthcare | Equity | 1.81% |
| Thermo Fisher Scientific Inc. | Healthcare | Forgn. Eq | 1.77% |
| Abbott Laboratories | Healthcare | Forgn. Eq | 1.76% |
| Alkem Laboratories Ltd. | Healthcare | Equity | 1.75% |
| Intuitive Surgical Inc. (USA) | Healthcare | Forgn. Eq | 1.64% |
| Amgen Inc. (USA) | Healthcare | Forgn. Eq | 1.42% |
| Biocon Ltd. | Healthcare | Equity | 1.40% |
| Novo Nordisk A/S - ADR | Healthcare | ADS/ADR | 1.32% |
| Ipca Laboratories Ltd. | Healthcare | Equity | 1.32% |
| Gilead Sciences Inc. (USA) | Healthcare | Forgn. Eq | 1.23% |
| Zydus Lifesciences Ltd. | Healthcare | Equity | 1.22% |
| Danaher Corporation | Healthcare | Forgn. Eq | 1.19% |
| Medtronic | Healthcare | Forgn. Eq | 0.99% |
| Stryker Corp | Healthcare | Forgn. Eq | 0.98% |
| Vertex Pharmaceuticals Inc. (USA) | Healthcare | Forgn. Eq | 0.94% |
| Narayana Hrudayalaya Ltd. | Healthcare | Equity | 0.90% |
| Gland Pharma Ltd. | Healthcare | Equity | 0.85% |
| Ajanta Pharma Ltd. | Healthcare | Equity | 0.81% |
| Syngene International Ltd. | Healthcare | Equity | 0.79% |
| Glaxosmithkline Pharmaceuticals Ltd. | Healthcare | Equity | 0.70% |
| Piramal Pharma Ltd. | Healthcare | Equity | 0.69% |
| Regeneron Pharmaceuticals Inc | Healthcare | Forgn. Eq | 0.65% |
| Global Health Ltd. | Healthcare | Equity | 0.64% |
| Aster DM Healthcare Ltd. | Healthcare | Equity | 0.47% |
| Becton Dickinson And Co | Healthcare | Forgn. Eq | 0.45% |
| Agilent Technologies Inc | Healthcare | Forgn. Eq | 0.31% |
| Iqvia Holdings | Healthcare | Forgn. Eq | 0.31% |
| Illumina Inc. (USA) | Healthcare | Forgn. Eq | 0.16% |
See All
Minimum investments
Min. for 1st investment
Not Supported
Min. for 2nd investment
Not Supported
Min. for SIP
₹100
Returns and rankings
Annualised returns
Absolute returns
| Name | 1Y | 3Y | 5Y | All |
|---|---|---|---|---|
| Fund returns | +9.1% | +19.4% | +13.6% | +15.6% |
| Category average (Equity Sectoral) | -2.1% | +22.1% | +14.6% | -- |
| Rank (Equity Sectoral) | 1 | 12 | 9 | -- |
Exit load, stamp duty and tax
Exit load
Nil
Stamp duty on investment: 0.005% (from July 1st, 2020)
from July 1st 2020
Tax implication
If you redeem within one year, returns are taxed at 20%. If you redeem after one year, returns exceeding Rs 1.25 lakh in a financial year are taxed at 12.5%.
Check past data
Fund management
BJBhavesh JainOct 2021 - PresentView details
BJ
Bhavesh Jain
Oct 2021 - Present
View details
AVAmit VoraFeb 2021 - PresentView details
AV
Amit Vora
Feb 2021 - Present
View details
About Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth is a Equity Mutual Fund Scheme launched by Edelweiss Mutual Fund. This scheme was made available to investors on 30 Apr 2008. Bhavesh Jain is the Current Fund Manager of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth fund. The fund currently has an Asset Under Management(AUM) of ₹1,68,087 Cr and the Latest NAV as of 16 Jan 2026 is ₹21.32.
The Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth is rated Very High risk. Minimum SIP Investment is set to ₹100.
;
Investment Objective
The scheme seeks to invest in stocks comprising of the MSCI India Domestic & World Healthcare 45 Index with the objective to provide investment returns that, before expenses, closely corresponds to the returns equivalent to the index, subject to tracking errors.
Fund benchmarkMSCI India Domestic & World Healthcare 45 Index
Fund house
Rank (total assets)#15 in India
Total AUM₹1,68,086.73 Cr
Date of Incorporation30 Apr 2008
Launch Date30 Apr 2008
AddressEdelweiss HouseOff C.S.T. Road,Kalina Mumbai 400098
Websitewww.karvymfs.com
AddressKarvy House, No. 46, 8-2-609/K, Avenue 4, Street No.1 Banjara Hills,